Skip to main content

Month: January 2024

EXEL Industries : First quarter 2023–2024 sales: up 8.1%

First quarter 2023–2024 sales: up 8.1% 11.0% organic growth in line with last fiscal yearThe EXEL Industries Group posted revenue of €200.1 million for the first quarter of the 2023–2024 fiscal year, up 8.1%, driven mainly by organic growth in sugar beet harvesting and industry. Growth at constant consolidation scope and foreign exchange rates was 11.0%. The change in consolidation scope arising from the Devaux group acquisition in June 2023 contributed €1.3 million to first quarter revenue.3-monthsales(October 2023-December 2023)   2022–2023 2023–2024 Change (reported) Change (LFL*)Reported Reported €m % €m %             AGRICULTURAL SPRAYING   89.0 90.9 +1.9 +2.1% +5.6 +6.3%SUGAR BEET HARVESTING ...

Continue reading

Tryg Forsikring A/S – Financial highlights – 2023

Tryg Forsikring’s full annual report for 2023 will be published 9 February 2024 Annual report 2023 for the entire Tryg Group is available on Tryg.com. Insurance service result of DKK 6,399m (DKK 6,292m1) in 2023 impacted positively by a good growth of 4.8%, DKK 711m (DKK 406m) synergies from the RSA Scandinavia acquisition, significantly higher interest rates but also weakened Swedish and Norwegian currencies. The combined ratio was 82.8 (83.2) driven by a generally improved underlying performance but also a year with high level of weather related claims in all our main markets. Investment results of DKK 615m primarily impacted by positive returns from equities and fixed-income asset classes. Overall pre-tax profit was DKK 5,199m and profit after tax was DKK 3,993m Financial highlights 2023Premium growth of 4.8% in local currencies Insurance...

Continue reading

BioSenic presents new Phase 3 data on JTA-004 to treat severe osteoarthritis pain at the 2024 OARSI World Congress

PRESS RELEASE BioSenic presents new Phase 3 data on JTA-004 to treat severe osteoarthritis pain at the 2024 OARSI World Congress Using a recently published approach to stratify patients with knee osteoarthritis, an external post hoc analysis of Phase 3 data showed JTA-004 is safe and efficient for treating pain symptoms in the most severely affected patients. Mont-Saint-Guibert, Belgium, January 25 2024, 7.00 am CET – BioSenic (Euronext Brussels and Paris: BIOS), the clinical-stage company specializing in serious autoimmune and inflammatory diseases and cell therapy, will for the first time share post hoc data on its late-clinical asset JTA-004 at the Osteoarthritis Research Society International (OARSI) World Congress 2024. The post hoc analysis of a Phase 3 study found that a single injection of JTA-004 was safe and efficacious for patients...

Continue reading

MAISONS DU MONDE: FOURTH-QUARTER AND FULL-YEAR 2023 TRADING UPDATE

PRESS RELEASENantes, 25 January 2024 FOURTH-QUARTER AND FULL-YEAR 2023 TRADING UPDATE Q4 sales down -7.9%, marking sequential improvementvs preceding 9 months in a persistently challenging environment Full-Year sales at -9.3%, vs c.-10% adjusted guidanceGroup GMV: Q4 at €367.9m (-5.5% yoy), FY at €1,263.9m (-5.5% yoy)o/w Marketplace GMV: Q4 at €49.4m (+24.4% yoy), FY at €176.9M (+45.7% yoy) Group sales: Q4 at €329.6m (-7.9% yoy), FY at €1,125.4m (-9.3% yoy) FY 2023 adjusted guidance on EBIT and FCF confirmedSALES DETAILS  Q4 2023 Q4 2022   %Change   FY 2023   FY 2022   %Change  (in EUR million)  Group GMV 367.9 389.1 -5.5% 1 263.9 1 337.1 -5.5%Sales 329.6 358.0 -7.9% 1 125.4 1 240.4 -9.3%Sales by product category            Decoration 215.2 240.3...

Continue reading

Nokia Corporation Financial Report for Q4 and full year 2023

Nokia CorporationFinancial Statement Release25 January 2024 at 08:00 EET Nokia Corporation Financial Report for Q4 and full year 2023 Improving order intake and cash flow at the end of a challenging yearNet sales declined 21% y-o-y in constant currency (-23% reported) in Q4 as macroeconomic uncertainty continues to pressure operator spending. Full year net sales declined 8% y-o-y in constant currency (-11% reported). In Q4 the environment remained challenging however there are now signs of stabilization with improving order trends. Comparable gross margin in Q4 declined by 40bps y-o-y to 43.1% (reported declined 100bps to 41.8%). Significant improvements in Mobile Networks and Cloud and Network Services were offset by lower contribution from Nokia Technologies which benefited from a significant one-off in the prior year. Q4 comparable...

Continue reading

STMicroelectronics Reports Q4 and FY 2023 Financial Results

PR No: C3230C STMicroelectronics Reports Q4 and FY 2023 Financial ResultsQ4 net revenues $4.28 billion; gross margin 45.5%; operating margin 23.9%; net income $1.08 billion FY net revenues $17.29 billion; gross margin 47.9%; operating margin 26.7%; net income $4.21 billion Business outlook at mid-point: Q1 net revenues of $3.6 billion and gross margin of 42.3%Geneva, January 25, 2024 – STMicroelectronics N.V. (“ST”) (NYSE: STM), a global semiconductor leader serving customers across the spectrum of electronics applications, reported U.S. GAAP financial results for the fourth quarter ended December 31, 2023. This press release also contains non-U.S. GAAP measures (see Appendix for additional information). ST reported fourth quarter net revenues of $4.28 billion, gross margin of 45.5%, operating margin of 23.9%, and net income of $1.08...

Continue reading

CANADA CARBON INC. COMPLETES SHARES FOR DEBT TRANSACTION

Toronto, ON, Canada, Jan. 24, 2024 (GLOBE NEWSWIRE) — Further to its press release dated January 9, 2023, Canada Carbon Inc. (the “Company“) (TSX-V: CCB) (OTC: BRUZF) (Frankfurt: U7N1) announces that it has received TSXV approval for an agreement to extinguish an aggregate of $145,417 in debt owing to former Chief Financial Officer and Chief Executive Officer, Olga Nikitovic.  The debt was extinguished in consideration for the issuance of an aggregate of 4,406,575 common shares in the capital of the Company (the “Common Shares”) at a deemed price of $0.033 per share (the “Debt Settlement”). The Common Shares issued pursuant to the Debt Settlement will be subject to a statutory four month and one day hold period expiring on May 25, 2024. CANADA CARBON INC. “Ellerton Castor”Chief Executive Officer and DirectorContact...

Continue reading

Northfield Bancorp, Inc. Announces the Appointment of Dr. Rachana A. Kulkarni to Its Board of Directors

WOODBRIDGE, N.J., Jan. 24, 2024 (GLOBE NEWSWIRE) — NORTHFIELD BANCORP, INC. (Nasdaq:NFBK) (the “Company’), today announced that its Boards of Directors appointed Dr. Rachana A. Kulkarni as a director of both the Company and Northfield Bank effective February 1, 2024. Steven M. Klein, Chairman and CEO commented, “I’m pleased to announce that our Boards, under the leadership of its Nominating and Corporate Governance Committee, have appointed an esteemed and well-respected individual in Dr. Kulkarni. Rachana’s diverse skills, life experiences, and contributions to her community, will play a key role in our continued development and growth.” Dr. Kulkarni is President and Managing Partner of Medicor Cardiology, a leading cardiology group in New Jersey, and Regional Director of Cardiology of Barnabas Health Corp. Dr. Kulkarni, a resident...

Continue reading

Northfield Bancorp, Inc. Announces Fourth Quarter and Year End 2023 Results

NOTABLE ITEMS INCLUDE: FOURTH QUARTER 2023DILUTED EARNINGS PER SHARE OF $0.19 FOR THE FOURTH QUARTER OF 2023, COMPARED TO $0.19 FOR THE TRAILING QUARTER, AND $0.31 FOR THE FOURTH QUARTER OF 2022. NET INTEREST MARGIN COMPRESSION SLOWED TO EIGHT BASIS POINTS COMPARED TO A NINE BASIS POINT DECREASE FOR THE QUARTER ENDED SEPTEMBER 30, 2023. TOTAL DEPOSITS (EXCLUDING BROKERED) INCREASED BY APPROXIMATELY $110 MILLION, OR 12% ANNUALIZED, FROM SEPTEMBER 30, 2023. COST OF DEPOSITS WAS 175 BASIS POINTS FOR THE CURRENT QUARTER AS COMPARED TO 146 BASIS POINTS FOR THE TRAILING QUARTER. LOAN BALANCES DECLINED MODESTLY FROM SEPTEMBER 2023 WITH DECREASES IN MULTIFAMILY, COMMERCIAL MORTGAGE, ONE-TO FOUR FAMILY, AND CONSTRUCTION AND LAND LOANS BEING PARTIALLY OFFSET BY INCREASES IN HOME EQUITY LOANS AND LINES OF CREDIT, AND COMMERCIAL AND INDUSTRIAL LOANS. CREDIT...

Continue reading

Euronet Announces Fourth Quarter and Full Year 2023 Earnings Release Date and Conference Call Details

LEAWOOD, Kan., Jan. 24, 2024 (GLOBE NEWSWIRE) — Euronet (or the “Company”) (NASDAQ: EEFT) announced today it will release fourth quarter and full year 2023 earnings results prior to the market opening on Wednesday, February 7, 2024. Euronet will hold a conference call the same day at 9:00 a.m. Eastern Time to discuss the results. The conference call and accompanying slide show presentation will be accessible via webcast by following the link posted on http://ir.euronetworldwide.com. Participants wanting to access the conference call by telephone must register at Euronet Worldwide Fourth Quarter 2023 Earnings Call to receive dial-in information. While not required, it is recommended participants join the call five minutes prior to the event start. A webcast replay will be available beginning approximately one hour after the event...

Continue reading

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Important Notice for Investors:

The services and products offered by Goldalea Capital Ltd. are intended exclusively for professional market participants as defined by applicable laws and regulations. This typically includes institutional investors, qualified investors, and high-net-worth individuals who have sufficient knowledge, experience, resources, and independence to assess the risks of trading on their own.

No Investment Advice:

The information, analyses, and market data provided are for general information purposes only and do not constitute individual investment advice. They should not be construed as a basis for investment decisions and do not take into account the specific investment objectives, financial situation, or individual needs of any recipient.

High Risks:

Trading in financial instruments is associated with significant risks and may result in the complete loss of the invested capital. Goldalea Capital Ltd. accepts no liability for losses incurred as a result of the use of the information provided or the execution of transactions.

Sole Responsibility:

The decision to invest or not to invest is solely the responsibility of the investor. Investors should obtain comprehensive information about the risks involved before making any investment decision and, if necessary, seek independent advice.

No Guarantees:

Goldalea Capital Ltd. makes no warranties or representations as to the accuracy, completeness, or timeliness of the information provided. Markets are subject to constant change, and past performance is not a reliable indicator of future results.

Regional Restrictions:

The services offered by Goldalea Capital Ltd. may not be available to all persons or in all countries. It is the responsibility of the investor to ensure that they are authorized to use the services offered.

Please note: This disclaimer is for general information purposes only and does not replace individual legal or tax advice.